I can tell you for sure that Novartis is well aware of and is following the progress of OPT302.
It has been on their radar since the the phase 2 trial began.
Ann: Opthea's OPT-302 Granted Fast-Track for wet AMD, page-29
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.0¢ |
Change
-0.025(4.59%) |
Mkt cap ! $658.6M | |||
| Open | High | Low | Value | Volume |
| 54.5¢ | 54.5¢ | 51.5¢ | $425.3K | 807.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 18392 | 51.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.0¢ | 7021 | 7 |
View Market Depth
| Last trade - 12.59pm 28/08/2024 (20 minute delay) ? |
| OPT (ASX) Chart |